Expression of dendritic cells in follicular fluid of patients with polycystic ovary syndrome and its ;clinical significance

Fuying Tian,Huimei Gan,Nanni Peng,Feifei Gan,Jingyan Tian,Wanhua Zhen,Yonggang Duan,Zhiming Cai
DOI: https://doi.org/10.3969/cma.j.issn.1674-0785.2014.08.007
2014-01-01
Abstract:Objective To investigate the expression of dendritic cells (DC) in follicular fluid of polycystic ovarian syndrome (PCOS) patients and its clinical significance. Methods The samples of follicular fluid were collected from PCOS patients at the day of transvaginal oocyte retrieval (n=30). Patients with severe male factor infertility were set as control group (n=30). Phenotypes of DC were detected by flow cytometer and cytokines (TNF-α, IL-6, IL-10 and IL-23) in follicular fluid were assessed by the enzyme-linked immunosorbent assay (ELISA). Results A significant decrease of the percentage (16.22%±5.5%) of DC was found in PCOS follicular fluid compared with control (21.27%±5.5%). The mean fluorescence intensity of HLA-DR, which reflects DC maturation, correlated positively with serum level of E2 on the day of hCG administration (r=0.75, P<0.01). Serum E2 has a reverse correlation with the concentration of TNF-α in follicular fluid (r=-0.69, P<0.01). The level of cytokines (TNF-α, IL-6 and IL-10) increased significantly but proinflammatory cytokine IL-23 decrease in follicular fluid. The percentage of blood Treg cells increased significantly in carcinoma group compared with normal group but less than that of cancerous tissues in bladder carcinoma. Conclusion The decrease of follicular fluid DC from PCOS patients indicates an immunosuppressive regulatory profile in the microenvironment of ovarian follicle, which is associated with the dysfunction of folliculogenesis.
What problem does this paper attempt to address?